Lord Abbett & CO. LLC lowered its position in Cytokinetics, Incorporated ( NASDAQ:CYTK – Get Rating ) by 54.4% in the 3rd quarter, HoldingsChannel reports. The fund owned 3,758,622 shares of the biopharmaceutical company's stock after selling 4,490,529 shares during the period. Cytokinetics accounts for about 0.7% of Lord Abbett & CO. LLC's holdings, making the stock its 27th biggest position. Lord Abbett & CO. LLC's holdings in Cytokinetics were worth $182,106,000 at the end of the most recent quarter.

https://www.dailypolitical.com/2023/03/04/lord-abbett-co-llc-decreases-stake-in-cytokinetics-incorporated-nasdaqcytk.html

#dailypolitical